To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZFAND5TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
489 representative clones for gene ZFAND5 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BG720574 testis .a 1 to 631 1 to 631   tiling clone,   631/631
(100 %)
15 diff
(97.7 %id)
BI832398 brain, medulla .a 543 to 1234 32 to 733   tiling clone,   700/735
(95 %)
19 diff
(97.5 %id)
TI_57171250   .a 543 to 1234 32 to 733       700/735
(95 %)
19 diff
(97.5 %id)
DA290666 hippocampus .a 620 to 1171 2 to 553   tiling clone, capped   552/552
(100 %)
1 diff
(99.9 %id)
DA926036 small intestine .a 671 to 1243 2 to 574   tiling clone, capped   573/574
(99 %)
2 diff
(99.7 %id)
DB268317 uterus .a 674 to 1243 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
DA197952 brain .a 676 to 1244 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
NM_006007.2   .b 1 to 5728 1 to 5728 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 5728/5728
(100 %)
0 diff
(100 %id)
AI379933 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 290 to 747 1 to 458   tiling clone, Submitted on the opposite strand 458/458
(100 %)
1 diff
(99.8 %id)
BG207787   .b 553 to 1263 4 to 712   tiling clone,   712/817
(87 %)
13 diff
(98.5 %id)
CR624990 Placenta Cot 25-normalized .c 1 to 854 1 to 854 exact tiling clone,   854/854
(100 %)
0 diff
(100 %id)
DC352438 brain .c 42 to 572 1 to 531       531/531
(100 %)
1 diff
(99.9 %id)
CN286223 embryonic stem cells, cell lines H1, H7, andH9 .d 1 to 797 1 to 798   tiling clone,   798/798
(100 %)
3 diff
(99.7 %id)
CA943331 Pancreas, Purified pancreatic islet .d 102 to 599 510 to 13     Submitted on the opposite strand 498/514
(96 %)
0 diff
(100 %id)
DA098593 cerebellum .d 431 to 981 2 to 552   tiling clone, capped   551/551
(100 %)
0 diff
(100 %id)
AL041239 testis .d 696 to 875 1 to 179       179/179
(100 %)
3 diff
(98.4 %id)
DA301941 hippocampus .d 772 to 1351 2 to 581   tiling clone, capped   580/580
(100 %)
0 diff
(100 %id)
DB237979 trachea .d 984 to 1568 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
AA290717 germinal center B cell .d 991 to 1456 465 to 2     Submitted on the opposite strand 464/465
(99 %)
0 diff
(100 %id)
DA407171 thalamus .d 1081 to 1648 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
CV575532 cornea, eye .d 1109 to 1731 1 to 623       623/623
(100 %)
0 diff
(100 %id)
DA302033 hippocampus .d 1275 to 1825 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
CA389935 eye, RPE/choroid .d 1345 to 1988 1 to 644   tiling clone,   644/644
(100 %)
1 diff
(99.9 %id)
DB223036 trachea .d 1430 to 2001 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DB194539 trachea .d 1432 to 1978 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DR033707 brain, Right frontal lobe .d 1451 to 1986 16 to 555       540/555
(97 %)
6 diff
(99.0 %id)
BX497009 Liver .d 1456 to 1911 1 to 456       456/456
(100 %)
1 diff
(99.8 %id)
DA114708 cerebellum .d 1465 to 2058 2 to 596   capped   595/595
(100 %)
1 diff
(99.9 %id)
DB286258 uterus .d 1497 to 2048 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
AL700050 human skeletal muscle .d 1562 to 2296 1 to 733   tiling clone,   733/767
(95 %)
7 diff
(99.1 %id)
DB285166 uterus .d 1586 to 2133 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
BX493049   .d 1593 to 2119 1 to 526       526/526
(100 %)
1 diff
(99.9 %id)
DA461222 tongue, tumor tissue .d 1686 to 2264 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
DA406264 thalamus .d 1727 to 2287 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
BE061105 breast .d 1733 to 2086 16 to 369       354/369
(95 %)
6 diff
(98.4 %id)
CN293833 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 1933 to 2531 9 to 607       599/607
(98 %)
0 diff
(100 %id)
DA016007 adrenal gland .d 1934 to 2497 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BX643979   .d 1936 to 2232 1 to 297       297/297
(100 %)
13 diff
(95.7 %id)
BX478867   .d 2052 to 2442 1 to 391       391/391
(100 %)
0 diff
(100 %id)
CN288393 embryonic stem cells, cell lines H1, H7, andH9 .d 2125 to 2561 1 to 437   tiling clone,   437/437
(100 %)
1 diff
(99.8 %id)
DB239329 trachea .d 2185 to 2770 2 to 588   capped   587/587
(100 %)
2 diff
(99.7 %id)
DB152015 thymus .d 2187 to 2762 2 to 579   capped   578/578
(100 %)
3 diff
(99.5 %id)
DA907610   .d 2216 to 2769 2 to 556   tiling clone, capped   555/555
(100 %)
4 diff
(99.3 %id)
DB142330 thymus .d 2370 to 2666 2 to 299   capped   298/298
(100 %)
2 diff
(99.4 %id)
DB230127 trachea .d 2447 to 3033 2 to 589   tiling clone, capped   588/588
(100 %)
1 diff
(99.9 %id)
BX497631 Liver .d 2524 to 3145 1 to 622       622/622
(100 %)
10 diff
(98.4 %id)
CN411532 embryonic stem cells, cell lines H1, H7, andH9 .d 2557 to 3222 1 to 667       667/667
(100 %)
3 diff
(99.6 %id)
CN483395 eye .d 2563 to 3180 1 to 619       619/619
(100 %)
5 diff
(99.2 %id)
DA549871   .d 2606 to 3196 2 to 592   tiling clone, capped   591/591
(100 %)
1 diff
(99.9 %id)
AI188762 placenta .d 2730 to 3348 19 to 637     Submitted on the opposite strand 619/637
(97 %)
14 diff
(97.9 %id)
CF528613 placenta .d 2730 to 3291 17 to 578     Submitted on the opposite strand 562/578
(97 %)
6 diff
(99.0 %id)
CF528694 placenta .d 2730 to 3127 17 to 414     Submitted on the opposite strand 398/414
(96 %)
6 diff
(98.6 %id)
DA390012 thalamus .d 2748 to 3332 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
DB240351 trachea .d 2752 to 3325 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
CN411531 embryonic stem cells, DMSO-treated H9 cellline .d 2832 to 3271 1 to 442       442/442
(100 %)
3 diff
(99.4 %id)
DA842057 placenta .d 2893 to 3444 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
DA290465 hippocampus .d 2894 to 3478 2 to 586   capped   585/585
(100 %)
2 diff
(99.7 %id)
CA976171 sciatic nerve .d 3166 to 4084 1 to 933 V205X E208X tiling clone,   933/935
(99 %)
30 diff
(96.8 %id)
BM924718 pooled colon, kidney, stomach .e 1 to 818 1 to 819 E140G E145G L173F F174V C175L ... tiling clone,   1042/1136
(91 %)
40 diff
(96.5 %id)
DA015469 adrenal gland .e 33 to 588 2 to 557   capped   556/562
(98 %)
2 diff
(99.7 %id)
DA292390 hippocampus .e 96 to 678 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DA784270 brain .e 98 to 673 2 to 578   capped   577/577
(100 %)
3 diff
(99.5 %id)
DA872897 Prostate .e 98 to 674 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
DB202723 trachea .e 98 to 680 2 to 585   capped   584/584
(100 %)
3 diff
(99.5 %id)
DA146392 amygdala .e 99 to 556 2 to 459   capped   458/458
(100 %)
1 diff
(99.8 %id)
DB209687 trachea .e 101 to 658 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DB267088 uterus .e 101 to 476 2 to 377   capped   376/376
(100 %)
0 diff
(100 %id)
DA824757 pericardium .e 102 to 661 2 to 562   capped   561/562
(99 %)
4 diff
(99.3 %id)
DA959359 Spleen .e 104 to 661 2 to 560   capped   559/559
(100 %)
3 diff
(99.5 %id)
DA153946 amygdala .e 106 to 615 2 to 511   capped   510/510
(100 %)
1 diff
(99.9 %id)
DA199668 brain .e 106 to 664 2 to 560   capped   559/560
(99 %)
2 diff
(99.7 %id)
DA204317 brain .e 106 to 692 2 to 588   capped   587/588
(99 %)
1 diff
(99.9 %id)
DA294097 hippocampus .e 106 to 690 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
DB177944 kidney, tumor tissue .e 106 to 664 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DB256518 uterus .e 106 to 665 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA443551 tongue, tumor tissue .e 107 to 672 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
BG705344 brain, hippocampus .e 109 to 777 1 to 669   tiling clone,   669/671
(99 %)
10 diff
(98.6 %id)
BG285172 adenocarcinoma, cell line, Prostate .e 114 to 759 1 to 643       643/643
(100 %)
4 diff
(99.4 %id)
DB174251 kidney, tumor tissue .e 119 to 682 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA167573 amygdala .e 122 to 686 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA392231 thalamus .e 122 to 692 2 to 572   capped   571/580
(98 %)
1 diff
(99.9 %id)
DA207009 brain .e 127 to 692 2 to 567   capped   566/567
(99 %)
1 diff
(99.9 %id)
DA327736 hippocampus .e 127 to 659 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
DA938065 Spleen .e 127 to 678 2 to 553   capped   552/552
(100 %)
3 diff
(99.5 %id)
DA301690 hippocampus .e 140 to 696 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
NM_001102420.1   .f 1 to 5868 1 to 5868 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 5868/5868
(100 %)
0 diff
(100 %id)
TI_44165290   .f 30 to 716 70 to 767       698/768
(90 %)
17 diff
(97.8 %id)
TI_44000281   .f 30 to 788 72 to 826       755/826
(91 %)
15 diff
(98.2 %id)
TI_44000386   .f 30 to 827 79 to 888       810/907
(89 %)
29 diff
(96.9 %id)
TI_45210166   .f 30 to 689 77 to 745       669/932
(71 %)
25 diff
(97.4 %id)
TI_45211242   .f 30 to 730 114 to 812       699/813
(85 %)
13 diff
(98.5 %id)
TI_45212257   .f 30 to 723 76 to 771       694/771
(90 %)
10 diff
(98.8 %id)
TI_44349305   .f 30 to 730 78 to 779       702/781
(89 %)
14 diff
(98.3 %id)
CN367081 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 35 to 651 1 to 617   tiling clone,   617/617
(100 %)
2 diff
(99.7 %id)
BM846696 myeloma .f 40 to 568 1 to 529       529/529
(100 %)
1 diff
(99.9 %id)
DA207528 brain .f 41 to 601 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA526335 brain .f 41 to 591 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
BG037063 testis .f 43 to 744 6 to 699       694/704
(98 %)
17 diff
(97.6 %id)
BC027707 Lung, small cell carcinoma .f 51 to 1420 1 to 1370 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1370/1370
(100 %)
1 diff
(100.0 %id)
CN367080 embryonic stem cells, cell lines H1, H7, andH9 .f 62 to 687 1 to 626       626/626
(100 %)
1 diff
(99.9 %id)
BE795854 lung, small cell carcinoma .f 70 to 850 1 to 785   tiling clone,   785/989
(79 %)
11 diff
(98.9 %id)
CN367079 embryonic stem cells, cell lines H1, H7, andH9 .f 110 to 736 1 to 627       627/627
(100 %)
1 diff
(99.9 %id)
DN995194 brain, whole brain .f 154 to 1047 1 to 888       890/894
(99 %)
24 diff
(97.4 %id)
BG706230 brain, hypothalamus .f 258 to 1040 1 to 784       784/785
(99 %)
17 diff
(97.9 %id)
AI440474 B-cell, chronic lymphotic leukemia .f 272 to 887 1 to 616     Submitted on the opposite strand 616/616
(100 %)
1 diff
(99.9 %id)
AI658995 Prostate .f 272 to 929 1 to 658     Submitted on the opposite strand 658/658
(100 %)
2 diff
(99.7 %id)
BF432471 brain, glioblastoma (pooled) .f 290 to 928 1 to 639     Submitted on the opposite strand 639/640
(99 %)
2 diff
(99.7 %id)
BG335871 choriocarcinoma, placenta .f 325 to 1147 1 to 827       827/902
(91 %)
31 diff
(96.6 %id)
BG336330 choriocarcinoma, placenta .f 325 to 1147 1 to 826       826/984
(83 %)
33 diff
(96.7 %id)
DA483802 brain .f 329 to 684 2 to 357   capped   356/356
(100 %)
0 diff
(100 %id)
BX460334 brain, fetal brain .f 331 to 1385 1 to 1049 A143L P144L E145N L146C K148N ...     1049/1091
(96 %)
12 diff
(99.0 %id)
DA707958   .f 347 to 809 2 to 468   capped   467/467
(100 %)
4 diff
(99.2 %id)
TI_45209078   .f 359 to 1154 139 to 947       809/1084
(74 %)
35 diff
(96.8 %id)
TI_44344747   .f 366 to 1065 95 to 798       704/804
(87 %)
14 diff
(98.3 %id)
DA740906   .f 373 to 885 2 to 514   capped   513/513
(100 %)
3 diff
(99.5 %id)
DB245070 uterus, tumor tissue .f 373 to 936 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA507640 brain .f 375 to 936 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA697579   .f 375 to 942 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA711754   .f 375 to 702 2 to 329   capped   328/328
(100 %)
0 diff
(100 %id)
TI_57201303   .f 376 to 1152 30 to 816       784/816
(96 %)
22 diff
(97.4 %id)
DA022708   .f 378 to 944 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA510185 brain .f 378 to 936 2 to 562   capped   561/561
(100 %)
3 diff
(99.5 %id)
DA694509   .f 378 to 651 2 to 275   capped   274/274
(100 %)
0 diff
(100 %id)
BM564961 insulinoma, Pancreas .f 395 to 994 1 to 600       600/601
(99 %)
6 diff
(99.1 %id)
BP360086 thalamus .f 410 to 991 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
CR747411 pooled .f 451 to 922 1 to 472       472/472
(100 %)
1 diff
(99.8 %id)
BM822686 stomach .f 473 to 819 1 to 347       347/347
(100 %)
0 diff
(100 %id)
DA997622   .f 517 to 1075 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA375159 thalamus .f 518 to 1075 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
AK025782   .f 538 to 2832 1 to 2295 exact available from FLJ, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 2295/2295
(100 %)
2 diff
(100.0 %id)
TI_227713416   .f 552 to 1420 925 to 63 N6T AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 863/975
(88 %)
18 diff
(98.2 %id)
AA384765 thyroid gland .f 563 to 786 1 to 224       224/224
(100 %)
0 diff
(100 %id)
AF062347   .f 563 to 2835 1 to 2273 exact tiling clone,   2273/2273
(100 %)
2 diff
(100.0 %id)
BP206797 coronary artery .f 568 to 1153 1 to 588       588/588
(100 %)
3 diff
(99.5 %id)
DC338904 subthalamic nucleus .f 571 to 1075 1 to 506       506/506
(100 %)
2 diff
(99.7 %id)
DC299810   .f 576 to 1135 1 to 561       561/561
(100 %)
2 diff
(99.7 %id)
DA389893 thalamus .f 581 to 1178 2 to 600   capped   599/599
(100 %)
2 diff
(99.7 %id)
DA750972   .f 582 to 1111 2 to 531   capped   530/530
(100 %)
2 diff
(99.7 %id)
CD106676 brain, Pituitary .f 584 to 1435 1 to 853 exact     853/853
(100 %)
2 diff
(99.8 %id)
CX867415 embryonic stem .f 586 to 1390 1 to 805 exact   Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 805/805
(100 %)
1 diff
(99.9 %id)
DA830948 placenta .f 588 to 1316 2 to 731   capped   730/783
(93 %)
13 diff
(98.4 %id)
CB046170 2 pooled tumors (clear cell type), Kidney .f 599 to 1290 7 to 698       692/698
(99 %)
10 diff
(98.6 %id)
DA712328   .f 599 to 1144 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
AA228112 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f 609 to 1079 1 to 469       469/469
(100 %)
4 diff
(99.2 %id)
AA410182 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f 609 to 1032 1 to 424       424/424
(100 %)
2 diff
(99.6 %id)
DA080830 cerebellum .f 636 to 1208 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
BF979860 testis .f 787 to 1602 809 to 1       809/891
(90 %)
15 diff
(98.4 %id)
AA228021 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f 1156 to 1628 473 to 1       473/473
(100 %)
1 diff
(99.8 %id)
AA410201 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f 1209 to 1628 420 to 1       420/420
(100 %)
1 diff
(99.8 %id)
DB376351 placenta .f 2102 to 2579 478 to 1   tiling clone,   478/478
(100 %)
3 diff
(99.4 %id)
CX867334 embryonic stem .f 2194 to 2832 666 to 27   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 640/640
(100 %)
6 diff
(99.1 %id)
DA859397 placenta .g 1 to 542 2 to 543   tiling clone, capped   542/542
(100 %)
0 diff
(100 %id)
DA215924 brain .g 14 to 379 2 to 367   capped   366/366
(100 %)
0 diff
(100 %id)
DA990340 synovial membrane tissue from rheumatioidarthritis .g 28 to 536 2 to 510   capped   509/509
(100 %)
1 diff
(99.9 %id)
TI_157605938   .g 199 to 690 55 to 551     Submitted on the opposite strand 497/1086
(45 %)
20 diff
(98.2 %id)
TI_158435645   .g 199 to 827 69 to 703   tiling clone, Submitted on the opposite strand 635/954
(66 %)
13 diff
(98.7 %id)
AA928000 pooled .g 203 to 714 1 to 512     Submitted on the opposite strand 512/512
(100 %)
12 diff
(97.7 %id)
AA283706 germinal center B cell .g 204 to 730 1 to 524     Submitted on the opposite strand 524/524
(100 %)
10 diff
(98.1 %id)
AA292081 ovarian tumor, ovary .g 204 to 634 1 to 430     Submitted on the opposite strand 430/430
(100 %)
2 diff
(99.6 %id)
AA906434 pooled .g 204 to 647 1 to 446     Submitted on the opposite strand 446/446
(100 %)
6 diff
(98.7 %id)
AI066535 pooled .g 204 to 717 1 to 514     Submitted on the opposite strand 514/514
(100 %)
1 diff
(99.9 %id)
AI028401 B-cell, chronic lymphotic leukemia .g 204 to 637 1 to 434     Submitted on the opposite strand 434/434
(100 %)
0 diff
(100 %id)
AW028683 fibrotheoma, ovary .g 204 to 634 1 to 431     Submitted on the opposite strand 431/431
(100 %)
4 diff
(99.1 %id)
BF111638 pooled .g 204 to 710 1 to 507     Submitted on the opposite strand 507/507
(100 %)
3 diff
(99.5 %id)
BF195689 fibrotheoma, ovary .g 204 to 706 1 to 503     Submitted on the opposite strand 503/503
(100 %)
4 diff
(99.3 %id)
AA463929 ovarian tumor, ovary .g 205 to 536 1 to 330     Submitted on the opposite strand 330/330
(100 %)
6 diff
(98.2 %id)
BF515966   .g 205 to 794 1 to 590     Submitted on the opposite strand 590/590
(100 %)
2 diff
(99.7 %id)
AA904673 pooled .g 207 to 612 1 to 404     Submitted on the opposite strand 404/404
(100 %)
6 diff
(98.6 %id)
N89570 lung .g 208 to 660 4 to 454   tiling clone, Submitted on the opposite strand 451/456
(98 %)
5 diff
(99.0 %id)
AA496626 ovarian tumor, ovary .g 209 to 633 8 to 433     Submitted on the opposite strand 426/433
(98 %)
6 diff
(98.7 %id)
AI524723 B-cell, chronic lymphotic leukemia .g 222 to 722 1 to 501     Submitted on the opposite strand 501/501
(100 %)
2 diff
(99.7 %id)
H92321 eye, retina .g 255 to 593 1 to 340     Submitted on the opposite strand 340/340
(100 %)
4 diff
(98.9 %id)
R67089 placenta .g 264 to 702 1 to 440     Submitted on the opposite strand 440/441
(99 %)
11 diff
(97.6 %id)
R77953 placenta .g 266 to 644 1 to 381     Submitted on the opposite strand 381/381
(100 %)
7 diff
(98.2 %id)
R77710 placenta .g 269 to 375 1 to 106     Submitted on the opposite strand 106/106
(100 %)
1 diff
(99.1 %id)
AA749103 germinal center B cell .g 269 to 505 1 to 235     Submitted on the opposite strand 235/235
(100 %)
4 diff
(98.3 %id)
DB444517 testis .g 276 to 701 1 to 427       427/427
(100 %)
2 diff
(99.6 %id)
AA811774 germinal center B cell .g 295 to 628 1 to 334     Submitted on the opposite strand 334/334
(100 %)
5 diff
(98.6 %id)
AA805962 germinal center B cell .g 300 to 492 1 to 193     Submitted on the opposite strand 193/193
(100 %)
0 diff
(100 %id)
BI052711 placenta_normal .g 354 to 747 1 to 397       397/398
(99 %)
17 diff
(95.8 %id)
AV692710 hepatocellular carcinoma .g 354 to 954 1 to 601       601/624
(96 %)
16 diff
(97.5 %id)
AL700248 human skeletal muscle .g 378 to 861 1 to 484       484/484
(100 %)
1 diff
(99.8 %id)
AA292118 ovarian tumor, ovary .g 413 to 891 486 to 12     Submitted on the opposite strand 475/497
(95 %)
0 diff
(100 %id)
T56541.
matches multiple genes
fetal spleen, Spleen .g 415 to 553 49 to 189     also hits gene PRRC1 141/191
(73 %)
4 diff
(98.0 %id)
AA464065 ovarian tumor, ovary .g 417 to 887 479 to 11     Submitted on the opposite strand 469/479
(97 %)
0 diff
(100 %id)
R66212 placenta .g 429 to 884 470 to 2     Submitted on the opposite strand 469/471
(99 %)
0 diff
(100 %id)
AA333197 Embryo, 8 weeks .g 440 to 788 1 to 353       353/360
(98 %)
9 diff
(97.5 %id)
AW965333   .g 441 to 915 1 to 475       475/503
(94 %)
19 diff
(96.3 %id)
R77709 placenta .g 441 to 884 458 to 2     Submitted on the opposite strand 457/458
(99 %)
0 diff
(100 %id)
W16812 lung .g 456 to 830 382 to 1     Submitted on the opposite strand 382/386
(98 %)
8 diff
(98.0 %id)
AA410908 ovarian tumor, ovary .g 472 to 882 427 to 16     Submitted on the opposite strand 412/427
(96 %)
0 diff
(100 %id)
R78324 placenta .g 486 to 887 412 to 1     Submitted on the opposite strand 412/488
(84 %)
12 diff
(97.6 %id)
AA746011 germinal center B cell .g 504 to 627 1 to 124     Submitted on the opposite strand 124/124
(100 %)
0 diff
(100 %id)
H92382 eye, retina .g 541 to 856 328 to 1     Submitted on the opposite strand 328/353
(92 %)
18 diff
(95.0 %id)
AA496509 ovarian tumor, ovary .g 578 to 887 325 to 16     Submitted on the opposite strand 310/325
(95 %)
0 diff
(100 %id)
AA361524   .g 656 to 924 1 to 269       269/269
(100 %)
2 diff
(99.3 %id)
AW955435   .g 657 to 1147 1 to 492   tiling clone,   492/492
(100 %)
12 diff
(97.6 %id)
DW460713 Liver .g 738 to 855 17 to 135       119/135
(88 %)
6 diff
(95.6 %id)
AK290849   .g 809 to 2146 1 to 1338 exact tiling clone,   1338/1338
(100 %)
2 diff
(99.9 %id)
DC428346   .g 809 to 1394 1 to 586       586/586
(100 %)
2 diff
(99.7 %id)
CB115433 Liver .g 859 to 1381 1 to 522       522/522
(100 %)
8 diff
(98.5 %id)
AI825842 colon, colon tumor, RER+ .h 1 to 462 459 to 1   tiling clone,   459/459
(100 %)
2 diff
(99.6 %id)
AI823414 Kidney .h 38 to 458 421 to 1   tiling clone,   421/421
(100 %)
1 diff
(99.8 %id)
NM_001102421.1   .h 224 to 5954 1 to 5731   RefSeq, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 5731/5731
(100 %)
0 diff
(100 %id)
AW161082 brain, frontal lobe .h 235 to 621 1 to 387   tiling clone,   387/387
(100 %)
0 diff
(100 %id)
DA032060   .h 237 to 592 2 to 357   capped   356/356
(100 %)
0 diff
(100 %id)
BM562217 amelanotic melanoma, cell line, skin .h 281 to 1052 1 to 776       776/1058
(73 %)
25 diff
(97.7 %id)
BP431938   .h 287 to 494 1 to 208       208/208
(100 %)
0 diff
(100 %id)
BP431911   .h 288 to 494 1 to 207       207/207
(100 %)
0 diff
(100 %id)
BC011018 Skin, melanotic melanoma, high MDR. .h 388 to 1739 1 to 1352   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1352/1353
(99 %)
3 diff
(99.8 %id)
AI244054 Kidney .h 495 to 775 1 to 281     Submitted on the opposite strand 281/281
(100 %)
0 diff
(100 %id)
AI382512 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 495 to 701 1 to 207     Submitted on the opposite strand 207/207
(100 %)
0 diff
(100 %id)
AF062346   .h 500 to 2921 1 to 2418       2418/2418
(100 %)
9 diff
(99.7 %id)
BX390834   .h 541 to 1432 893 to 1 P9R V206G A207R E208K I210F ...   Submitted on the opposite strand 893/893
(100 %)
35 diff
(96.1 %id)
BM924540 pooled colon, kidney, stomach .h 614 to 1517 1 to 920 L163S T164Y G165R F166V D167*     920/1038
(88 %)
36 diff
(96.6 %id)
CU456118 epidermis .h 676 to 1153 494 to 17     Submitted on the opposite strand 478/502
(95 %)
6 diff
(98.9 %id)
BC073131 Eye, retinoblastoma .h 723 to 2918 1 to 2196   available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 2196/2196
(100 %)
1 diff
(100.0 %id)
BU176262 eye, retinoblastoma .h 724 to 1545 1 to 831 K200E     831/914
(90 %)
22 diff
(97.6 %id)
AA290935 germinal center B cell .h 754 to 1203 448 to 1     Submitted on the opposite strand 448/448
(100 %)
3 diff
(99.4 %id)
CF551809 Pooled muscle (cardiac and skeletal) .h 798 to 1683 1 to 888       888/888
(100 %)
5 diff
(99.5 %id)
CX752238 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .h 803 to 1506 715 to 26   AAA Submitted on the opposite strand 690/819
(84 %)
20 diff
(97.6 %id)
BM686104 eye, RPE and Choroid .h 897 to 1439 559 to 18   AAA Submitted on the opposite strand 544/542
(100 %)
2 diff
(99.7 %id)
AL134742 brain .h 930 to 1698 1 to 771       771/776
(99 %)
6 diff
(99.3 %id)
BI910661 leukocyte .h 935 to 1757 7 to 826       819/826
(99 %)
18 diff
(97.9 %id)
TI_57237574   .h 935 to 1757 34 to 853       819/853
(96 %)
18 diff
(97.9 %id)
DA130533 alzheimer cortex .h 941 to 1514 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA365140 subthalamic nucleus .h 949 to 1499 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
T31648 colon, embryo .h 973 to 1288 1 to 316       316/316
(100 %)
0 diff
(100 %id)
BQ010900 placenta .h 974 to 1439 484 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 466/466
(100 %)
0 diff
(100 %id)
R76203 placenta .h 993 to 1370 386 to 2     Submitted on the opposite strand 385/389
(98 %)
9 diff
(97.7 %id)
DA812325 ovary, tumor tissue .h 1038 to 1424 2 to 388   capped   387/387
(100 %)
1 diff
(99.8 %id)
BM921512 pooled brain, lung, testis .h 1047 to 2003 20 to 987       969/1092
(88 %)
35 diff
(96.8 %id)
DB110075 thymus .h 1048 to 1627 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
AI080681 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 1059 to 1513 455 to 1       455/455
(100 %)
0 diff
(100 %id)
AA232786 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 1060 to 1439 1 to 380   fully sequenced,   380/380
(100 %)
1 diff
(99.8 %id)
CA425621 cell lines, Chondrosarcoma .h 1066 to 1758 711 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 693/693
(100 %)
0 diff
(100 %id)
DA699495   .h 1073 to 1597 2 to 526   capped   525/525
(100 %)
0 diff
(100 %id)
DA618010   .h 1076 to 1648 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA129198 alzheimer cortex .h 1077 to 1652 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
CA748687 Alveolar Macrophage, lung .h 1091 to 1750 678 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 660/660
(100 %)
0 diff
(100 %id)
CR624137 fetal brain .h 1102 to 2899 1 to 1798       1798/1798
(100 %)
0 diff
(100 %id)
BI602618 brain, hypothalamus .h 1102 to 1890 1 to 792       792/792
(100 %)
9 diff
(98.9 %id)
F06223 brain, total brain .h 1107 to 1417 1 to 311       311/311
(100 %)
0 diff
(100 %id)
TI_45213542   .h 1108 to 1890 93 to 878       786/878
(89 %)
10 diff
(98.9 %id)
AL535627 brain, fetal brain .h 1111 to 1982 11 to 880   fully sequenced,   870/880
(98 %)
8 diff
(99.1 %id)
CN389032 embryonic stem cells, cell lines H1, H7, andH9 .h 1128 to 1805 1 to 678       678/678
(100 %)
0 diff
(100 %id)
AI122783 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 1128 to 1639 512 to 1       512/512
(100 %)
0 diff
(100 %id)
T31494 colon, embryo .h 1141 to 1424 1 to 284       284/284
(100 %)
0 diff
(100 %id)
DA593370 lung .h 1178 to 1749 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
AU133888 ovary, tumor tissue .h 1178 to 1952 2 to 779   capped   778/779
(99 %)
8 diff
(99.0 %id)
DA056543 cerebellum .h 1183 to 1790 2 to 609   capped   608/608
(100 %)
0 diff
(100 %id)
BX401368   .h 1194 to 2135 941 to 1     Submitted on the opposite strand 941/941
(100 %)
2 diff
(99.8 %id)
BG291929 bladder, transitional cell papilloma, cell line .h 1198 to 1974 1 to 773       773/807
(95 %)
37 diff
(95.5 %id)
AA278973 germinal center B cell .h 1219 to 1639 421 to 1       421/421
(100 %)
0 diff
(100 %id)
AA737626 germinal center B cell .h 1222 to 1506 296 to 12   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 285/285
(100 %)
0 diff
(100 %id)
BU509408 leiomyosarcoma, uterus .h 1247 to 2108 12 to 880       869/894
(97 %)
20 diff
(97.8 %id)
N42305 melanocyte .h 1257 to 1503 247 to 1     Submitted on the opposite strand 247/247
(100 %)
0 diff
(100 %id)
BG105714 adrenal cortex carcinoma, cell line, adrenal gland .h 1259 to 2007 1 to 750       750/809
(92 %)
6 diff
(99.3 %id)
DA131267 alzheimer cortex .h 1267 to 1823 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
CB129880 Liver .h 1271 to 1830 1 to 560       560/560
(100 %)
0 diff
(100 %id)
CN389028 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 1273 to 2041 17 to 784       768/784
(97 %)
6 diff
(99.3 %id)
BU171286 melanotic melanoma, skin .h 1273 to 2126 10 to 866       857/866
(98 %)
13 diff
(98.5 %id)
BQ880753 dorsal root ganglia .h 1273 to 2172 39 to 946       908/946
(95 %)
6 diff
(99.4 %id)
AA285111 ovarian tumor, ovary .h 1279 to 1541 263 to 1     Submitted on the opposite strand 263/263
(100 %)
0 diff
(100 %id)
X75687   .h 1280 to 1506 1 to 226   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 226/226
(100 %)
3 diff
(98.7 %id)
AW630845 2 pooled high-grade transitional celltumors, genitourinary tract .h 1286 to 1702 1 to 417       417/417
(100 %)
0 diff
(100 %id)
BM465123 eye, retinoblastoma .h 1344 to 2091 1 to 763       763/1021
(74 %)
17 diff
(98.4 %id)
DR760646 embryonic stem .h 1379 to 2141 7 to 769       763/769
(99 %)
9 diff
(98.9 %id)
CR612072 B cells (Ramos cell line) Cot 25-normalized .h 1407 to 2934 1 to 1528   tiling clone,   1528/1528
(100 %)
0 diff
(100 %id)
AA233347 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 1409 to 1750 342 to 1   fully sequenced,   342/342
(100 %)
0 diff
(100 %id)
BP375697 uterus .h 1415 to 1982 1 to 568       568/568
(100 %)
0 diff
(100 %id)
AW631275 2 pooled high-grade transitional celltumors, genitourinary tract .h 1430 to 1878 1 to 449       449/449
(100 %)
0 diff
(100 %id)
DA360128 subthalamic nucleus .h 1436 to 1992 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA221685 brain .h 1458 to 2120 2 to 664   capped   663/663
(100 %)
1 diff
(99.9 %id)
BP260519 small intestine .h 1459 to 2040 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA571194 whole embryo, mainly head .h 1469 to 2324 2 to 854   capped   853/853
(100 %)
3 diff
(99.7 %id)
DA899327 skeletal muscle .h 1478 to 2045 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
CX868015 embryonic stem .h 1492 to 2295 1 to 804   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 804/804
(100 %)
0 diff
(100 %id)
BG170879 hypernephroma, cell line, Kidney .h 1497 to 2270 1 to 762       762/951
(80 %)
27 diff
(97.2 %id)
CB117976 brain .h 1560 to 1776 1 to 217       217/217
(100 %)
0 diff
(100 %id)
BM696347 eye, lens .h 1565 to 2025 1 to 461       461/461
(100 %)
0 diff
(100 %id)
BG620611 placenta .h 1570 to 2344 1 to 782       782/784
(99 %)
16 diff
(98.0 %id)
T30904 brain .h 1570 to 1883 1 to 314       314/314
(100 %)
0 diff
(100 %id)
BQ637348 eye, retina .h 1582 to 2211 1 to 630       630/630
(100 %)
0 diff
(100 %id)
BF725237 eye, Iris .h 1586 to 1938 1 to 353       353/353
(100 %)
0 diff
(100 %id)
BU508056 leiomyosarcoma, uterus .h 1605 to 2667 1 to 1072       1072/1158
(92 %)
28 diff
(97.6 %id)
Z42327 brain, total brain .h 1610 to 1881 1 to 272       272/272
(100 %)
0 diff
(100 %id)
AA298197 Bone .h 1622 to 1926 1 to 305       305/305
(100 %)
0 diff
(100 %id)
CX867608 embryonic stem .h 1624 to 2365 1 to 742   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 742/742
(100 %)
0 diff
(100 %id)
BQ722766 sympathetic trunk .h 1638 to 2525 1 to 902       902/903
(99 %)
32 diff
(96.5 %id)
BP261367 small intestine .h 1644 to 2222 1 to 579       579/579
(100 %)
0 diff
(100 %id)
AV682830 hepatocellular carcinoma .h 1648 to 2051 1 to 404       404/404
(100 %)
0 diff
(100 %id)
CB155401 brain .h 1685 to 2251 1 to 567       567/567
(100 %)
0 diff
(100 %id)
DA413414 thalamus .h 1688 to 2224 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
BP308079 brain .h 1689 to 2269 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BX104930 placenta .h 1719 to 2461 1 to 743       743/743
(100 %)
0 diff
(100 %id)
T34113 blood, white blood cells .h 1729 to 2049 1 to 321       321/321
(100 %)
0 diff
(100 %id)
C04716 heart .h 1736 to 2045 1 to 310       310/310
(100 %)
0 diff
(100 %id)
BG403731 bladder, transitional cell papilloma, cell line .h 1742 to 2505 1 to 766       766/812
(94 %)
18 diff
(97.8 %id)
BG697958 skin .h 1758 to 2577 1 to 823       823/827
(99 %)
15 diff
(98.2 %id)
BI859193 breast, mammary adenocarcinoma, cell line .h 1819 to 2599 1 to 779       779/779
(100 %)
5 diff
(99.4 %id)
BG675497 skin .h 1829 to 2634 8 to 815       808/955
(84 %)
10 diff
(99.0 %id)
AA370253 Prostate .h 1847 to 2121 1 to 275       275/275
(100 %)
0 diff
(100 %id)
TI_149271382   .h 1853 to 2656 883 to 84   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 800/979
(81 %)
13 diff
(98.7 %id)
FN048957 breast carcinoma .h 1887 to 1993 1 to 107       107/107
(100 %)
0 diff
(100 %id)
AL157637 brain .h 1910 to 2075 1 to 166       166/166
(100 %)
0 diff
(100 %id)
AW804390 uterus .h 1911 to 2014 111 to 9       103/111
(92 %)
0 diff
(100 %id)
BM541445 leiomyosarcoma, uterus .h 1926 to 2874 1 to 956       956/1054
(90 %)
25 diff
(97.7 %id)
BF526063 brain, glioblastoma with EGFR amplification .h 1930 to 2708 1 to 773       773/971
(79 %)
28 diff
(97.2 %id)
BM466086 embryonal carcinoma, cell line, testis .h 1938 to 2918 1025 to 46   AAA Submitted on the opposite strand 980/1075
(91 %)
33 diff
(97.0 %id)
N75197 cochlea, ear .h 1945 to 2332 1 to 387   fully sequenced,   387/387
(100 %)
1 diff
(99.8 %id)
AL565999 brain, fetal brain .h 1962 to 2899 937 to 1   fully sequenced,   937/937
(100 %)
7 diff
(99.3 %id)
BE005734 breast_normal .h 1967 to 2164 1 to 198       198/198
(100 %)
0 diff
(100 %id)
FN104946 breast carcinoma .h 1973 to 2088 120 to 1     Submitted on the opposite strand 120/120
(100 %)
3 diff
(97.5 %id)
AA302875 adipose tissue, white .h 1976 to 2264 1 to 289       289/289
(100 %)
0 diff
(100 %id)
BQ718510 sympathetic trunk .h 1986 to 2895 1 to 919       919/919
(100 %)
28 diff
(97.0 %id)
BE738221 brain, glioblastoma .h 2010 to 2857 862 to 8       855/867
(98 %)
0 diff
(100 %id)
TI_154044422   .h 2016 to 2918 1002 to 108   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 895/896
(99 %)
55 diff
(93.9 %id)
BX455036 brain, fetal brain .h 2023 to 2916 896 to 1       896/898
(99 %)
4 diff
(99.6 %id)
N77557 multiple sclerosis lesions .h 2031 to 2490 1 to 461   fully sequenced,   461/461
(100 %)
2 diff
(99.6 %id)
AA032297 uterus .h 2034 to 2185 1 to 152       152/152
(100 %)
0 diff
(100 %id)
DA802529 brain .h 2037 to 2585 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
N75091 multiple sclerosis lesions .h 2061 to 2571 1 to 511   fully sequenced,   511/511
(100 %)
2 diff
(99.7 %id)
TI_149280626   .h 2063 to 2654 679 to 88   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 592/695
(85 %)
0 diff
(100 %id)
BU679356 lung, Primary Lung Epithelial Cells .h 2063 to 2654 610 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 592/600
(98 %)
0 diff
(100 %id)
BM699840 eye, lens .h 2063 to 2466 1 to 404   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 404/404
(100 %)
0 diff
(100 %id)
TI_149301862   .h 2082 to 2918 917 to 91   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 827/957
(86 %)
17 diff
(98.3 %id)
TI_154108088   .h 2101 to 2918 888 to 76   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 813/950
(85 %)
7 diff
(99.3 %id)
DV461509 cochlea, ear .h 2104 to 2368 265 to 1     Submitted on the opposite strand 265/265
(100 %)
0 diff
(100 %id)
DV459152 cochlea, ear .h 2104 to 2368 1 to 265       265/265
(100 %)
0 diff
(100 %id)
TI_149297191   .h 2108 to 2918 893 to 94   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 800/919
(87 %)
37 diff
(96.0 %id)
CV810419 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .h 2115 to 2918 829 to 21   AAA Submitted on the opposite strand 809/880
(91 %)
27 diff
(97.0 %id)
DR157458 human embryonic stem cells differentiated toan early endodermal cell type .h 2134 to 2917 787 to 4     Submitted on the opposite strand 784/787
(99 %)
0 diff
(100 %id)
BM906524 ovary (pool of 3) .h 2143 to 2826 700 to 14     Submitted on the opposite strand 687/1047
(65 %)
11 diff
(99.0 %id)
TI_149273347   .h 2143 to 2918 862 to 91   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 772/839
(92 %)
5 diff
(99.5 %id)
BM725787 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 2158 to 2560 1 to 403   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 403/403
(100 %)
0 diff
(100 %id)
BQ437851 melanotic melanoma, skin .h 2169 to 2918 820 to 64   AAA Submitted on the opposite strand 757/855
(88 %)
11 diff
(98.8 %id)
CV808398 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .h 2170 to 2918 783 to 33   AAA Submitted on the opposite strand 751/754
(99 %)
20 diff
(97.4 %id)
N27998 melanocyte .h 2172 to 2557 1 to 390   fully sequenced,   390/390
(100 %)
1 diff
(99.8 %id)
CN389037 embryonic stem cells, DMSO-treated H9 cellline .h 2178 to 2903 1 to 726       726/726
(100 %)
0 diff
(100 %id)
TI_154097112   .h 2179 to 2918 823 to 89   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 735/805
(91 %)
12 diff
(98.6 %id)
CA447381 Chondrosarcoma, Left Pelvis .h 2187 to 2918 748 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 730/730
(100 %)
2 diff
(99.8 %id)
BQ008880 Chondrosarcoma, Left Pelvis .h 2195 to 2918 740 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 722/729
(99 %)
1 diff
(99.9 %id)
BG741604 skin .h 2254 to 3059 1 to 805       805/807
(99 %)
12 diff
(98.6 %id)
BU675680 lung, Primary Lung Epithelial Cells .h 2266 to 2918 671 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 653/653
(100 %)
0 diff
(100 %id)
CX867935 embryonic stem .h 2280 to 2918 664 to 26   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 639/639
(100 %)
3 diff
(99.6 %id)
BM994178 lung, Metastatic Chondrosarcoma .h 2281 to 2918 656 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 638/638
(100 %)
0 diff
(100 %id)
N80416 multiple sclerosis lesions .h 2287 to 2575 1 to 297   fully sequenced,   297/297
(100 %)
1 diff
(99.7 %id)
TI_149307747   .h 2291 to 2918 742 to 115   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 628/911
(68 %)
6 diff
(99.4 %id)
BM979469 lung, Primary Lung Epithelial Cells .h 2291 to 2918 646 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 628/633
(99 %)
6 diff
(99.1 %id)
FN110359 breast carcinoma .h 2300 to 2379 78 to 1     Submitted on the opposite strand 78/79
(98 %)
1 diff
(98.8 %id)
N22321 cochlea, ear .h 2302 to 2656 360 to 1   fully sequenced,   360/360
(100 %)
6 diff
(98.4 %id)
CA314491 Human Lung Epithelial cells, lung .h 2307 to 2918 630 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 612/620
(98 %)
0 diff
(100 %id)
T16664   .h 2330 to 2654 325 to 1       325/325
(100 %)
0 diff
(100 %id)
BU077800 insulinoma, Pancreas .h 2331 to 2878 553 to 6     Submitted on the opposite strand 548/553
(99 %)
0 diff
(100 %id)
CX869944 embryonic stem .h 2333 to 2918 604 to 19   AAA Submitted on the opposite strand 586/586
(100 %)
0 diff
(100 %id)
CX867526 embryonic stem .h 2335 to 2918 610 to 26   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 585/585
(100 %)
3 diff
(99.5 %id)
BM850710 stomach .h 2335 to 2905 1 to 571       571/571
(100 %)
0 diff
(100 %id)
CA440650 Chondrosarcoma, Left Pubic Bone .h 2343 to 2918 594 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 576/576
(100 %)
0 diff
(100 %id)
CA425009 cell lines, Chondrosarcoma .h 2347 to 2918 590 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 572/572
(100 %)
0 diff
(100 %id)
FN060980 breast carcinoma .h 2353 to 2415 1 to 63       63/63
(100 %)
0 diff
(100 %id)
Z39132 brain, total brain .h 2357 to 2654 298 to 1       298/298
(100 %)
1 diff
(99.7 %id)
TI_149295168   .h 2371 to 3253 968 to 93   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 876/953
(91 %)
17 diff
(98.3 %id)
AI683811 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .h 2397 to 2918 522 to 1       522/522
(100 %)
0 diff
(100 %id)
AL709040 human skeletal muscle .h 2414 to 3102 1 to 692     Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 692/692
(100 %)
6 diff
(99.2 %id)
DB358025 whole embryo, mainly head .h 2417 to 2918 501 to 1       501/501
(100 %)
1 diff
(99.9 %id)
BG057321 blood, lymphocyte .h 2417 to 2917 501 to 1       501/501
(100 %)
0 diff
(100 %id)
CD677464 eye, Trabecular meshwork .h 2424 to 2916 1 to 493       493/493
(100 %)
0 diff
(100 %id)
CN478482 eye, lens .h 2436 to 2918 501 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 483/483
(100 %)
0 diff
(100 %id)
DB524817 testis .h 2437 to 2918 1 to 482     Submitted on the opposite strand 482/482
(100 %)
0 diff
(100 %id)
DB572027 hypothalamus .h 2444 to 2918 1 to 475     Submitted on the opposite strand 475/475
(100 %)
0 diff
(100 %id)
AA693500   .h 2445 to 2918 474 to 1       474/474
(100 %)
0 diff
(100 %id)
AI653997 serous papillary carcinoma, high grade, 2pooled tumors, uterus .h 2445 to 2919 475 to 1       475/475
(100 %)
0 diff
(100 %id)
BQ029989 lung, Metastatic Chondrosarcoma .h 2446 to 2918 491 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 473/473
(100 %)
0 diff
(100 %id)
CN389033 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 2448 to 2918 513 to 43   AAA Submitted on the opposite strand 471/471
(100 %)
1 diff
(99.8 %id)
CN389029 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .h 2449 to 2589 1 to 141       141/141
(100 %)
0 diff
(100 %id)
DB522367 testis .h 2451 to 2918 1 to 468     Submitted on the opposite strand 468/468
(100 %)
0 diff
(100 %id)
FN154107 breast carcinoma .h 2454 to 2551 1 to 97       97/97
(100 %)
1 diff
(99.0 %id)
N62274 multiple sclerosis lesions .h 2461 to 2918 462 to 1   fully sequenced,   462/462
(100 %)
5 diff
(99.0 %id)
AI431532 lymph node, lymphoma, follicular mixed small and largecell .h 2463 to 2919 457 to 1       457/457
(100 %)
0 diff
(100 %id)
DB565050 hypothalamus .h 2464 to 2918 1 to 455     Submitted on the opposite strand 455/455
(100 %)
0 diff
(100 %id)
BM673681 eye, eye anterior segment .h 2470 to 2918 467 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 449/449
(100 %)
0 diff
(100 %id)
DB525428 testis .h 2472 to 2918 1 to 447     Submitted on the opposite strand 447/447
(100 %)
0 diff
(100 %id)
AI632712 Kidney .h 2472 to 2920 449 to 1       449/449
(100 %)
0 diff
(100 %id)
AA975536 carcinoid, lung .h 2475 to 2921 447 to 1       447/447
(100 %)
0 diff
(100 %id)
FN099929 breast carcinoma .h 2489 to 2581 1 to 93       93/93
(100 %)
0 diff
(100 %id)
GD146094   .h 2500 to 2643 1 to 145       145/150
(96 %)
6 diff
(96.0 %id)
AI124024 heart .h 2506 to 2918 431 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 413/413
(100 %)
0 diff
(100 %id)
AA576042 breast, breast tumor .h 2508 to 2918 432 to 22   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 411/411
(100 %)
0 diff
(100 %id)
AA582148 germ cell tumor .h 2508 to 2918 411 to 1       411/411
(100 %)
0 diff
(100 %id)
EC528579 Prostate .h 2517 to 2606 1 to 90       90/90
(100 %)
4 diff
(95.6 %id)
N21339 melanocyte .h 2527 to 2918 393 to 1   fully sequenced,   393/393
(100 %)
1 diff
(99.8 %id)
BM677902 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 2530 to 2918 405 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 387/387
(100 %)
0 diff
(100 %id)
N52321 multiple sclerosis lesions .h 2541 to 2919 382 to 1   fully sequenced,   382/382
(100 %)
5 diff
(98.7 %id)
DB509386 testis .h 2545 to 2918 1 to 374     Submitted on the opposite strand 374/374
(100 %)
0 diff
(100 %id)
N67994 multiple sclerosis lesions .h 2545 to 2916 372 to 1   fully sequenced,   372/372
(100 %)
0 diff
(100 %id)
AA974076 pooled germ cell tumors .h 2546 to 2919 374 to 1       374/374
(100 %)
0 diff
(100 %id)
AI748830 aorta .h 2546 to 2912 367 to 1       367/367
(100 %)
0 diff
(100 %id)
BG620568 placenta .h 2568 to 2918 1 to 351   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 351/351
(100 %)
0 diff
(100 %id)
AI077579 senescent fibroblast .h 2583 to 2918 346 to 11   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 336/336
(100 %)
0 diff
(100 %id)
AI244544 Kidney .h 2592 to 2918 327 to 1       327/327
(100 %)
0 diff
(100 %id)
AI421363 brain, glioblastoma (pooled) .h 2597 to 2919 323 to 1       323/323
(100 %)
0 diff
(100 %id)
AA847542 colon, colon tumor .h 2628 to 2918 327 to 37   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 291/291
(100 %)
0 diff
(100 %id)
CN389031 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 2638 to 2918 1 to 281   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 281/281
(100 %)
0 diff
(100 %id)
CA337665 1st pharyngeal arch (pooled) .h 2647 to 2918 1 to 272   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 272/272
(100 %)
0 diff
(100 %id)
AA814563 brain, substantia nigra .h 2648 to 2918 297 to 27   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 271/271
(100 %)
0 diff
(100 %id)
T35613 lung .h 2692 to 2918 227 to 1     Submitted on the opposite strand 227/227
(100 %)
0 diff
(100 %id)
Z28664 leg muscle, skeletal muscle .h 2694 to 2918 237 to 13   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 225/225
(100 %)
0 diff
(100 %id)
DB371673 ovary, tumor tissue .h 2701 to 3255 554 to 1       554/556
(99 %)
9 diff
(98.4 %id)
F13786   .h 2704 to 2918 225 to 11   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 215/215
(100 %)
0 diff
(100 %id)
D56703   .h 2704 to 2919 1 to 216       216/216
(100 %)
0 diff
(100 %id)
AI735379 aorta .h 2717 to 2921 205 to 1       205/205
(100 %)
0 diff
(100 %id)
DA407655 thalamus .h 2734 to 3282 2 to 550   tiling clone, capped   549/549
(100 %)
0 diff
(100 %id)
F01856 brain, total brain .h 2745 to 2916 172 to 1       172/174
(98 %)
0 diff
(100 %id)
T34827 brain .h 2746 to 2918 1 to 173       173/173
(100 %)
0 diff
(100 %id)
T30754 adrenal gland .h 2747 to 2914 1 to 168       168/168
(100 %)
0 diff
(100 %id)
F04733 brain, total brain .h 2761 to 2918 158 to 1       158/158
(100 %)
0 diff
(100 %id)
GD138165   .h 2780 to 2860 80 to 1     Submitted on the opposite strand 80/80
(100 %)
1 diff
(98.8 %id)
AA431564   .h 2812 to 2919 108 to 1       108/108
(100 %)
0 diff
(100 %id)
FN177432 breast carcinoma .h 2865 to 2974 109 to 1     Submitted on the opposite strand 109/112
(97 %)
3 diff
(97.4 %id)
DB164034 thymus .h 3017 to 3620 2 to 605   tiling clone, capped   604/604
(100 %)
1 diff
(99.9 %id)
G43282   .h 3021 to 3294 274 to 1     Submitted on the opposite strand 274/274
(100 %)
1 diff
(99.7 %id)
DA019531   .h 3138 to 3707 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
DB169036 kidney, tumor tissue .h 3220 to 3705 2 to 487   tiling clone, capped   486/486
(100 %)
3 diff
(99.4 %id)
BQ233465 epithelioid carcinoma, Pancreas .h 3476 to 4349 1 to 887   tiling clone,   887/888
(99 %)
20 diff
(97.8 %id)
BJ993607 hepatoblastoma .h 3660 to 4112 1 to 456   tiling clone,   456/456
(100 %)
3 diff
(99.4 %id)
DA058812 cerebellum .h 3872 to 4410 2 to 540   tiling clone, capped   539/539
(100 %)
0 diff
(100 %id)
BM015623 breast, mammary adenocarcinoma, cell line .h 4604 to 5363 15 to 766   tiling clone,   752/766
(98 %)
6 diff
(99.3 %id)
CR619628 fetal brain .h 4744 to 5944 1 to 1201   tiling clone,   1201/1201
(100 %)
0 diff
(100 %id)
BX442425 brain, fetal brain .h 4744 to 5770 1 to 1013   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1013/1013
(100 %)
21 diff
(98.0 %id)
CA429385 Cell Line, Chondrosarcoma .h 5072 to 5787 713 to 1       713/713
(100 %)
3 diff
(99.6 %id)
BU619236 Cell Line, Chondrosarcoma .h 5152 to 5787 635 to 1       635/635
(100 %)
1 diff
(99.9 %id)
DB295501   .h 5225 to 5772 550 to 1       550/557
(98 %)
3 diff
(99.5 %id)
BM680322 eye, fetal eye .h 5234 to 5772 1 to 538   AAA Submitted on the opposite strand 538/538
(100 %)
6 diff
(98.9 %id)
BJ993608 hepatoblastoma .h 5317 to 5736 420 to 1       420/420
(100 %)
0 diff
(100 %id)
AA976522 pooled germ cell tumors .h 5362 to 5772 411 to 1       411/411
(100 %)
0 diff
(100 %id)
BX489434 human skeletal muscle .h 5376 to 5954 605 to 20   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 586/586
(100 %)
7 diff
(98.9 %id)
AW149199 Kidney, renal cell tumor .h 5406 to 5627 222 to 1       222/222
(100 %)
0 diff
(100 %id)
DA914616   .i 1 to 567 2 to 568 exact tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
DB095754 testis .j 1 to 563 2 to 564   tiling clone, capped   563/563
(100 %)
1 diff
(99.9 %id)
DB143421 thymus .j 1 to 531 2 to 532   capped   531/531
(100 %)
2 diff
(99.7 %id)
DB270975 uterus .j 2 to 531 2 to 531   capped   530/530
(100 %)
1 diff
(99.9 %id)
DB145952 thymus .j 185 to 744 2 to 561   capped   560/560
(100 %)
3 diff
(99.5 %id)
DC350251 brain .j 252 to 820 1 to 569       569/569
(100 %)
2 diff
(99.7 %id)
DC409966 thymus .j 263 to 844 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DC359380 lung .j 268 to 845 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
CD642793 Embryonic Stem cells .j 279 to 1105 12 to 839   tiling clone,   828/851
(97 %)
14 diff
(98.4 %id)
CB985080 Pooled-Glandular .j 375 to 822 1 to 453       453/681
(66 %)
11 diff
(98.4 %id)
AL602156   .j 498 to 879 1 to 381       381/381
(100 %)
6 diff
(98.5 %id)
AK307376 uterus .j 757 to 1778 1 to 1022 exact tiling clone,   1022/1022
(100 %)
2 diff
(99.9 %id)
DC420554 uterus .j 757 to 1321 1 to 566       566/566
(100 %)
3 diff
(99.5 %id)
FN107236 breast carcinoma .j 805 to 903 107 to 10     Submitted on the opposite strand 98/116
(84 %)
0 diff
(100 %id)
DC412935 liver, tumor tissue .j 814 to 1348 1 to 537       537/537
(100 %)
4 diff
(99.3 %id)
DC413781 ovary, tumor tissue .j 817 to 1299 1 to 485       485/485
(100 %)
3 diff
(99.4 %id)
BU663516 blood .j 826 to 1378 1 to 553   tiling clone,   553/553
(100 %)
1 diff
(99.9 %id)
DA205177 brain .k 1 to 566 2 to 568 exact tiling clone, capped   567/567
(100 %)
2 diff
(99.7 %id)
TI_44165574   .l 1 to 672 126 to 797       679/798
(85 %)
8 diff
(99.0 %id)
BI669715 brain, hypothalamus .l 1 to 678 2 to 691       689/724
(95 %)
21 diff
(97.1 %id)
DA434154 tongue, tumor tissue .l 1 to 532 2 to 533   tiling clone, capped   532/532
(100 %)
0 diff
(100 %id)
BE675773 B-cell, chronic lymphotic leukemia .l 237 to 867 1 to 631     Submitted on the opposite strand 631/631
(100 %)
0 diff
(100 %id)
DA036936 breast .l 345 to 929 2 to 586   tiling clone, capped   585/585
(100 %)
0 diff
(100 %id)
ES313950 beard hair, skin .l 433 to 982 1 to 545       545/545
(100 %)
17 diff
(96.9 %id)
CD358875 testis .l 846 to 1576 1 to 734   tiling clone,   734/904
(81 %)
6 diff
(99.4 %id)
BX648551 Liver .l 1227 to 6844 1 to 5623 V13A tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 5623/5623
(100 %)
12 diff
(99.8 %id)
DA772850 brain .l 1415 to 1978 2 to 566   capped   565/565
(100 %)
4 diff
(99.3 %id)
DA373762 thalamus .l 1556 to 2098 2 to 548   capped   547/547
(100 %)
3 diff
(99.5 %id)
BU145921 dorsal root ganglia .l 1584 to 2411 843 to 1   tiling clone, Submitted on the opposite strand 843/970
(86 %)
20 diff
(98.0 %id)
BE699939 nervous_normal .l 1633 to 2008 1 to 376       376/376
(100 %)
3 diff
(99.3 %id)
AL699987 human skeletal muscle .l 1677 to 2397 1 to 727       727/727
(100 %)
4 diff
(99.5 %id)
BX470651   .l 1678 to 2262 1 to 588       588/588
(100 %)
2 diff
(99.7 %id)
DB282638 uterus .l 1904 to 2439 2 to 542   capped   541/541
(100 %)
2 diff
(99.7 %id)
BX476877   .l 2009 to 2575 1 to 572       572/572
(100 %)
2 diff
(99.7 %id)
DA233749 brain .l 2205 to 2779 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA961554 Spleen .l 2263 to 2838 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DB187889 liver, tumor tissue .l 2317 to 2835 12 to 530   tiling clone, capped   519/529
(98 %)
7 diff
(98.7 %id)
BF334150 colon .l 2529 to 2764 236 to 1       236/236
(100 %)
0 diff
(100 %id)
DB163729 thymus .l 2654 to 3239 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
CD643262 Embryonic Stem cells .l 2657 to 3396 1 to 740       740/740
(100 %)
4 diff
(99.5 %id)
BX497312 Liver .l 2676 to 3334 1 to 659       659/659
(100 %)
1 diff
(99.9 %id)
BX498706 Liver .l 2887 to 3253 1 to 367       367/367
(100 %)
0 diff
(100 %id)
DB150945 thymus .l 2904 to 3410 2 to 511   capped   510/511
(99 %)
4 diff
(99.3 %id)
DA341037 substantia nigra .l 2956 to 3506 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
DA515650 brain .l 3021 to 3562 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
BU188019 testis .l 3062 to 3867 1 to 816       816/816
(100 %)
23 diff
(97.2 %id)
H89571 cochlea, ear .l 3094 to 3487 1 to 396       396/397
(99 %)
7 diff
(98.3 %id)
H89593 cochlea, ear .l 3094 to 3480 1 to 392       392/396
(98 %)
8 diff
(98.0 %id)
AL041343 testis .l 3198 to 3825 1 to 628       628/628
(100 %)
9 diff
(98.6 %id)
AW166507 cervix .l 3453 to 3942 1 to 490     Submitted on the opposite strand 490/490
(100 %)
0 diff
(100 %id)
DB158487 thymus .l 3504 to 4109 2 to 607   capped   606/606
(100 %)
2 diff
(99.7 %id)
DB157318 thymus .l 3538 to 4110 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DA943187 Spleen .l 3681 to 4258 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
DB088470 testis .l 3684 to 4213 2 to 532   capped   531/531
(100 %)
1 diff
(99.9 %id)
AW367317 head_neck .l 3727 to 4313 587 to 4       584/599
(97 %)
0 diff
(100 %id)
DB186293 liver, tumor tissue .l 3735 to 4308 2 to 575   tiling clone, capped   574/574
(100 %)
1 diff
(99.9 %id)
DA938931 Spleen .l 3762 to 4294 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
AW075832 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .l 4028 to 4467 442 to 1       442/442
(100 %)
11 diff
(97.6 %id)
H89572 cochlea, ear .l 4049 to 4441 400 to 1       400/402
(99 %)
13 diff
(96.8 %id)
AV702306 adrenal gland .l 4072 to 4466 1 to 395   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 395/395
(100 %)
1 diff
(99.8 %id)
AA665619   .l 4139 to 4474 336 to 1       336/336
(100 %)
19 diff
(94.4 %id)
DW459282 Liver .l 4311 to 4448 12 to 149       138/149
(92 %)
6 diff
(96.0 %id)
DA962124 Spleen .l 4506 to 5046 2 to 544   capped   543/543
(100 %)
4 diff
(99.3 %id)
BX649046 Liver .l 4626 to 6844 1 to 2220   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 2220/2220
(100 %)
6 diff
(99.8 %id)
BQ878140 dorsal root ganglia .l 4687 to 5528 1 to 849   tiling clone,   849/859
(98 %)
19 diff
(97.8 %id)
C18781 placenta .l 4724 to 5041 1 to 317       317/318
(99 %)
3 diff
(99.1 %id)
D78741 placenta .l 4724 to 5111 1 to 388       388/388
(100 %)
1 diff
(99.8 %id)
N79101 multiple sclerosis lesions .l 4790 to 5195 1 to 410   fully sequenced,   410/410
(100 %)
7 diff
(98.3 %id)
N62343 multiple sclerosis lesions .l 5165 to 5440 279 to 1   fully sequenced,   279/279
(100 %)
1 diff
(99.7 %id)
BX498707 Liver .l 6213 to 6821 609 to 1       609/609
(100 %)
1 diff
(99.9 %id)
DA275394 corpus callosum .m 1 to 518 2 to 519   tiling clone, capped   518/518
(100 %)
3 diff
(99.5 %id)
BF966405 brain, hippocampus .m 329 to 957 1 to 623   tiling clone,   623/884
(70 %)
6 diff
(99.4 %id)
BF966534 brain, hippocampus .m 1033 to 1735 711 to 1   tiling clone,   711/711
(100 %)
18 diff
(97.5 %id)
DB307165 corpus callosum .m 1251 to 1780 531 to 1 V61G N62* tiling clone,   531/531
(100 %)
1 diff
(99.9 %id)
BX956236   .n 1 to 638 1 to 639 exact tiling clone,   639/639
(100 %)
2 diff
(99.7 %id)
CF597516 ovary .o 1 to 628 1 to 636 L58P Q59S S74* tiling clone,   634/800
(79 %)
21 diff
(97.4 %id)
DA140657 alzheimer cortex .p 1 to 525 2 to 527 R3L A4C V5C E6G D7G ... tiling clone, capped   526/526
(100 %)
2 diff
(99.7 %id)
DA257367 caudate nucleus .p 7 to 548 2 to 543 exact tiling clone, capped   542/542
(100 %)
0 diff
(100 %id)
BF115214 Kidney .q 1 to 454 461 to 9 exact tiling clone,   453/461
(98 %)
0 diff
(100 %id)
251 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI